Anxiety disorders are associated with quality of life impairment in patients with insulin-dependent type 2 diabetes: A case-control study

Revista Brasileira de Psiquiatria

Volumn 36, Issue 4, 2014, Pages 298-304

  dos Santos, Maria Augusta B ^a   Ceretta, Luciane B ^a   Réus, Gislaine Z ^a,b   Abelaira, Helena M ^a   Jornada, Luciano K ^a   Schwalm, Mágada T ^a   Neotti, Morgana V ^a   Tomazzi, Cristiane D ^a   Gulbis, Karina G ^a   Ceretta, Renan A ^a   Quevedo, João ^a,b  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Anxiety disorders; Comorbidities; Diabetes; Quality of life

Indexed keywords

CHOLESTEROL; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ANTIDIABETIC AGENT; INSULIN;

ACUTE HEART INFARCTION; AGE; AGORAPHOBIA; ANXIETY DISORDER; ARTICLE; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DISEASE ASSOCIATION; DSM-IV; EDUCATION; FEMALE; GENDER; GENERALIZED ANXIETY DISORDER; HEALTH SURVEY; HUMAN; HYPERTENSION; ICD-10; INFORMATION PROCESSING; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MINI INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSESSIVE COMPULSIVE DISORDER; PANIC; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRE; SOCIAL PHOBIA; WHOQOL BREF QUESTIONNAIRE; DIABETES MELLITUS, TYPE 2; INSULIN DEPENDENT DIABETES MELLITUS; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PSYCHOLOGY; SOCIAL ENVIRONMENT; SOCIOECONOMICS;

ANXIETY DISORDERS; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MARITAL STATUS; MULTIVARIATE ANALYSIS; QUALITY OF LIFE; QUESTIONNAIRES; SOCIAL ENVIRONMENT; SOCIOECONOMIC FACTORS;

EID: 84918828160     PISSN: 15164446     EISSN: None     Source Type: Journal    
DOI: 10.1590/1516-4446-2013-1230     Document Type: Article

References (30)

1. Rathmann W, Giani G. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:2568-9.
2. International Diabetes Federation [Internet]. Brussels: Diabetes Atlas 2012. [cited 2012 Sep 20].http://www.idf.org/diabetesatlas
3. Cnop M, Welsh N, Jonas JC, Jörns A, Lenzen S, Eizirik DL. Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: Many differences, few similarities. Diabetes. 2005;54:97-107.
4. Smith-Spangler CM, Bhattacharya J, Goldhaber-Fiebert JD. Diabetes, its treatment, and catastrophic medical spending in 35 developing countries. Diabetes Care. 2012;35:319-26.
5. Zhang Y, Hu G, Yuan Z, Chen L. Glycosylated hemoglobin in relationship to cardiovascular outcomes and death in patients with type 2 diabetes: a systematic review and meta-analysis. PLoS One. 2012;7:e42551.
6. Chaudhry R, Mishra P, Mishra J, Parminder S, Mishra BP. Psychiatric morbidity among diabetic patients: A hospital-based study. Ind Psychiatry J. 2010;19:47-9.
7. Wang MY, Tsai PS, Chou KR, Chen CM. A systematic review of the efficacy of non-pharmacological treatments for depression on glycaemic control in type 2 diabetics. J Clin Nurs. 2008;17:2524-30.
8. Katon WJ, Rutter C, Simon G, Lin EH, Ludman E, Ciechanowski P, et al. The association of comorbid depression with mortality in patients with type 2 diabetes. Diabetes Care. 2005;28:2668-72.
9. de Groot M, Anderson R, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a metaanalysis. Psychosom Med. 2001;63:619-30.
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). Arlington: American Psychiatric Publishing; 2000.
11. Grigsby AB, Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. Prevalence of anxiety in adults with diabetes: a systematic review. J Psychosom Res. 2002;53:1053-60.
12. Collins MM, Corcoran P, Perry IJ. Anxiety and depression symptoms in patients with diabetes. Diabet Med. 2009;26:153-61.
13. Mirza I, Jenkins R. Risk factors, prevalence, and treatment of anxiety and depressive disorders in pakistan: systematic review. BMJ. 2004;328:794.
14. Khuwaja AK, Kadir MM. Gender differences and clustering pattern of behavioural risk factors for chronic non-communicable diseases: community-based study from a developing country. Chronic Illn. 2010;6:163-70.
15. Khuwaja AK, Lalani SR, Azam IS, Rafique G, White F. Anxiety and depression among outpatients with type 2 diabetes: Amulti-centre study of prevalence and associated factors. Diabetol Metab Syndr. 2010;2:72.
16. Amorim P. Mini International Neropsychiatric Interview (MINI): validação de entrevista breve para os transtornos mentais. Rev Bras Psiquiatr. 2000;22:106-15.
17. Fleck MP, Louzada S, Xavier M, Chachamovich E, Vieira G, Santos L, et al. [Application of the Portuguese version of the instrument for the assessment of quality of life of the World Health Organization (WHOQOL-100)]. Rev Saude Publica. 1999;33:198-205.
18. Selvin E, Marinopoulos S, Berkenblit GT, Brancati FL, Powe NR, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004;141:421-31.
19. Baird TA, Parsons MW, Barber PA, Butcher KS, Desmond PM, Tress BM, et al. The influences of diabetes mellitus and hyperglycemia on stroke incidence and outcome. J Clin Neurosci. 2002;9: 618-26.
20. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension. 2001;37:1053-9.
21. Brenner BM, Cooper ME, de Zeeuw D, Keane WF, Mitch WE, Parving HH, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med. 2001;345:861-9.
22. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345:851-60.
23. Egede LE, Ellis C, Grubaugh AL. The effect of depression on selfcare behaviors and quality of care in a national sample of adults with diabetes. Gen Hosp Psychiatry. 2009;31:422-7.
24. Lee H-J, Chapa D, Kao CW, Jones D, Kapustin J, Smith J, et al. Depression, quality of life, and glycemic control in individuals with type 2 diabetes. J Am Acad Nurse Pract. 2009;21:214-24.
25. Lewko J, Zarzycki W, Krajewska-Kulak E. Relationship between the occurrence of symptoms of anxiety and depression, quality of life, and level of acceptance of illness in patients with type 2 diabetes. Saudi Med J. 2012;33:887-94.
26. Schram MT, Baan CA, Pouwer F. Depression and quality of life in patients with diabetes: a systematic review from the European Depression in Diabetes (EDID) research consortium. Curr Diabetes Rev. 2009;5:112-9.
27. Verma SK, Luo N, Subramaniam M, Sum CF, Stahl D, Liow PH, et al. Impact of depression on health related quality of life in patients with diabetes. Ann Acad Med Singapore. 2010;39:913-7.
28. Anderson RJ, Grigsby AB, Freedland KE, de Groot M, McGill JB, Clouse RE, et al. Anxiety and poor glycemic control: a meta-analytic review of the literature. Int J Psychiatry Med. 2002;32:235-47.
29. Soravia LM, Heinrichs M, Aerni A, Maroni C, Schelling G, Ehlert U, et al. Glucocorticoids reduce phobic fear in humans. Proc Natl Acad Sci U S A. 2006;103:5585-90.
30. Ceretta LB, Réus GZ, Abelaira HM, Jornada LK, Schwalm MT, Hoepers NJ, et al. Increased prevalence of mood disorders and suicidal ideation in type 2 diabetic patients. Acta Diabetol. 2012;49:S227-34.